Soluble CD4 enhances simian immunodeficiency virus SIVagm infection
about
Pathogenesis of human immunodeficiency virus infectionThe soluble form of the EIAV receptor encoded by an alternative splicing variant inhibits EIAV infection of target cellsGoing wild: lessons from naturally occurring T-lymphotropic lentivirusesFunctional dissection of CCR5 coreceptor function through the use of CD4-independent simian immunodeficiency virus strainsSoluble receptor-induced retroviral infection of receptor-deficient cellsSoluble V domain of Nectin-1/HveC enables entry of herpes simplex virus type 1 (HSV-1) into HSV-resistant cells by binding to viral glycoprotein DAntiretroviral therapy: strategies beyond single-agent reverse transcriptase inhibition.Envelope glycoproteins from human immunodeficiency virus types 1 and 2 and simian immunodeficiency virus can use human CCR5 as a coreceptor for viral entry and make direct CD4-dependent interactions with this chemokine receptorConformational changes induced in the human immunodeficiency virus envelope glycoprotein by soluble CD4 bindingNeutralizing antibodies to human immunodeficiency virus type-1 gp120 induce envelope glycoprotein subunit dissociation.Conformational changes induced in the envelope glycoproteins of the human and simian immunodeficiency viruses by soluble receptor bindingVirions of primary human immunodeficiency virus type 1 isolates resistant to soluble CD4 (sCD4) neutralization differ in sCD4 binding and glycoprotein gp120 retention from sCD4-sensitive isolates.Physicochemical dissociation of CD4-mediated syncytium formation and shedding of human immunodeficiency virus type 1 gp120.Human immunodeficiency virus type 2 infection and fusion of CD4-negative human cell lines: induction and enhancement by soluble CD4.Recombinant CD4-selected human immunodeficiency virus type 1 variants with reduced gp120 affinity for CD4 and increased cell fusion capacity.
P2860
Q24634681-A72A4E3C-EFB8-4878-9B8F-77BA115E7AF1Q27302868-391BEAEC-6DE2-45E6-9E9E-0C54FD71EABFQ31066870-9D2EFE78-26C6-4A47-9C99-249EEA6C6F76Q33647409-549AF844-847E-40CD-91F1-B87A3584152BQ33807796-36DB15F5-1094-4173-8F16-79012CF47BF8Q34233037-13EF3AE0-CA46-4A49-A98F-CE0B57885FF7Q35325810-83B138FD-F5C6-4253-BAF6-B0B128AB5DA8Q35890867-80E6CC2F-189B-419A-984A-9E500193097FQ36230268-344E3D93-5A2C-460D-A72E-1D57F7820AB8Q36366296-80ED28AB-1A0A-4247-AA05-333024F59F82Q36655317-73912DFB-B6A0-4440-B93D-8A5B4C34FA31Q36656036-3FDDD508-48B4-47F8-A8D9-E9577DED6ECCQ40045783-8BE0557A-B8DE-45BB-85EA-A31DDC718CD9Q40065815-81B5DA49-585E-4365-80CA-062C819C6CBFQ40106668-7444613C-F162-4CC5-8E6B-74D3F358E509
P2860
Soluble CD4 enhances simian immunodeficiency virus SIVagm infection
description
1990 nî lūn-bûn
@nan
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
1990年论文
@zh
1990年论文
@zh-cn
name
Soluble CD4 enhances simian immunodeficiency virus SIVagm infection
@en
type
label
Soluble CD4 enhances simian immunodeficiency virus SIVagm infection
@en
prefLabel
Soluble CD4 enhances simian immunodeficiency virus SIVagm infection
@en
P2093
P2860
P1433
P1476
Soluble CD4 enhances simian immunodeficiency virus SIVagm infection
@en
P2093
P2860
P304
P407
P577
1990-12-01T00:00:00Z